Your institution may have access to this item. Find your institution then sign in to continue.
Title
Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancer.
Authors
Fetscher, S.; Brugger, W.; Engelhardt, R.; Kanz, L.; Hasse, J.; Frommhold, H.; Wenger, M.; Lange, W.; Mertelsmann, R.